Senescent cells are damaged cells that stop dividing but refuse to die — they accumulate with age and pump out inflammatory cytokines (the SASP — senescence-associated secretory phenotype) that damage surrounding tissue and drive chronic inflammation, tissue deterioration, and age-related disease. Fisetin triggers apoptosis (programmed cell death) specifically in these senescent cells while leaving healthy cells unaffected. It does this by inhibiting the PI3K/AKT/mTOR survival pathway that senescent cells depend on. It also activates SIRT1, reduces NF-κB-driven inflammation, and has direct antioxidant activity.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.